AKT Kinase Inhibitor is primarily used in the field of oncology for targeting cancer cells. It works by inhibiting the AKT pathway, which is often overactive in various types of cancers, leading to uncontrolled cell growth and survival. By blocking this pathway, the inhibitor helps to reduce tumor growth and can enhance the effectiveness of other cancer therapies such as chemotherapy and radiation. It is also being researched for its potential in treating other diseases where the AKT pathway plays a critical role, such as diabetes and cardiovascular diseases. Clinical trials are ongoing to explore its efficacy and safety in these areas.